3625 results for «341»

Filter By

3625 results

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

Expanding indications for TAVI - moderate aortic stenosis and heart failure

09 Feb 2025 – From PCR Tokyo Valves 2025

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

Expanding indications for TAVI - moderate aortic stenosis and heart failure

TAVI burning issues

09 Feb 2025 – From PCR Tokyo Valves 2025

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

TAVI burning issues

1-year SELUTION DeNovo results: drug-eluting balloon strategy vs. systematic drug-eluting stent in de novo coronary disease

29 Oct 2025

Guillaume Bonnet interviews Christian Spaulding about the SELUTION DeNovo Trial he presented at TCT 2025, in San Francisco, and Salvatore Brugaletta provides his take on the clinical reading and interpretation for clinical practice.

Guillaume Bonnet

Author

Guillaume Bonnet

Author

Christian Spaulding

Author

Salvatore Brugaletta
1-year SELUTION DeNovo results: DEB strategy vs. systematic DES in de novo coronary disease

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

02 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine
Didn’t find what you were looking for?